• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    More On GLENMARK.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Glenmark Pharmaceuticals Ltd. (GLENMARK.NS)

    -NSE
    875.50 Up 10.35(1.20%) May 27, 5:59AM EDT
    Prev Close:865.15
    Open:869.80
    Bid:N/A
    Ask:875.50
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:868.15 - 892.70
    52wk Range:671.10 - 1,262.90
    Volume:753,872
    Avg Vol (3m):515,324
    Market Cap:247.01B
    P/E (ttm):35.02
    EPS (ttm):25.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.22
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, Latin America, Europe, the United States, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback